BWAY - שווי פעילות BrainsWay

BrainsWay Ltd. (BWAY) ensures scalability through the leasing of neurostimulation equipment, which creates a stable cash flow. The visualization of the company's market value, which currently stands at 412.88, confirms management's strategy to integrate their method into depression therapy standards. Device production is localized in Israel, while US logistics rely on redundant electronics supply chains.

Enterprise Value (EV) reflects the total cost of acquiring a business, summing market capitalization and net debt to eliminate the impact of financing structure. By analyzing the historical enterprise value chart, an investor can see the real scale of BrainsWay assets, where the high valuation is justified by the monopoly ownership of dTMS technologies and the deep integration of equipment into global psychiatric practice.